Synchronising drug and gene therapies

Cancer can be tackled with a combination of drug and genetic therapies, so that the effectiveness of individual treatments are enhanced.

YANG Yi Yan, Senior Research Fellow, Institute of Materials Research &...
YANG Yi Yan, Senior Research Fellow, Institute of Materials Research & Engineering
That is the result of  a study by Yi-Yan Yang and colleagues at the Institute of Bio-engineering and Nanotechnology in Singapore, published in the October issue of Nature Materials  (http://www.nature.com/naturematerials).
Beyond the promise for a more effective cure, achieving this synergistic effect also means that the dosage of anticancer treatments could be reduced.

The authors used biodegradable nanoparticles made from a polymer that has both a water-loving side and an oil-loving side. When placed in a water solution the polymer spontaneously forms nanoparticles in which the oil-loving part hides in the core, and the water-loving part lines the outside shell. If an oil-loving drug is present in the solution, it will be incorporated in the core. By contrast, the shell can be used to bind DNA or RNA.

The researchers loaded the nanoparticles with a potent anticancer drug and therapeutic gene, injected them in mouse tumours, and observed a significantly slower growth rate in the tumour.

17.11.2006

More on the subject:

Related articles

Photo

News • Emergency hospitalisation driver

Polypharmacy: hidden risks for older patients

Too many medicines, too many hospital visits: Inappropriate polypharmacy is a major driver of emergency hospital admissions among adults aged 65 and over, according to a new study.

Photo

Prof. Dr. Agnes Kant

‘Side effects are not a side issue’

Discovering knowledge about side effects needs to be faster and better. In her oration, Prof. Dr. Agnes Kant, Professor by special appointment of Innovation of Pharmacovigilance, calls for more…

Photo

News • Carotid artery stenosis

After stroke: new approach favors medication over surgery

A risky carotid artery operation may no longer be necessary for patients who suffer a stroke due to carotid artery narrowing, research suggests. Instead, medication-only treatment may also be viable.

Subscribe to Newsletter